Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akil, 2003, Catechol-O-methyltransferase genotype and dopamine regulation in the human brain, J Neuroscience, 23, 2008, 10.1523/JNEUROSCI.23-06-02008.2003
1994
Arseneault, 2004, Causal association between cannabis and psychosis, Br J Psychiatry, 184, 110, 10.1192/bjp.184.2.110
Bilder, 2004, The catechol-O-methyltransferase polymorphism, Neuropsychopharmacology, 29, 1943, 10.1038/sj.npp.1300542
Block, 2002, Effects of frequent marijuana use on memory-related regional cerebral blood flow, Pharmacol Biochem Behavior, 72, 237, 10.1016/S0091-3057(01)00771-7
Blumstein, 1995, Youth violence, guns, and the illicit-drug industry, J Crim Law Criminol, 86, 10, 10.2307/1143998
Bray, 2003, A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain, Am J Hum Genet, 73, 152, 10.1086/376578
Bunney, 2000, Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia, Brain Res Rev, 31, 138, 10.1016/S0165-0173(99)00031-4
Cannon, 2002, Evidence for early-childhood, pan-developmental impairment specific to adult schizophreniform disorder, Arch Gen Psychiatry, 59, 449, 10.1001/archpsyc.59.5.449
Carlsson, 2001, Interactions between monoamines, glutomate, and GABA in schizophrenia, Ann Rev Pharmacol Toxicol, 41, 237, 10.1146/annurev.pharmtox.41.1.237
Caspi, 2002, Role of genotype in the cycle of violence in maltreated children, Science, 297, 851, 10.1126/science.1072290
Chambers, 2003, Developmental neurocircuitry of motivation in adolescence, Am. J Psychiatry, 160, 1041, 10.1176/appi.ajp.160.6.1041
Cohen, 2003
Di Maggio, 2001, Evidence of a cohort effect for age at onset of schizophrenia, Am J Psychiatry, 158, 489, 10.1176/appi.ajp.158.3.489
Egan, 2001, Effect of COMT val 108/158 genotype on frontal lobe function and risk for schizophrenia, PNAS, 98, 6917, 10.1073/pnas.111134598
Erhrenreich, 1999, Specific attentional dysfunction in adults following early start of cannabis use, Psychopharmacology, 142, 295, 10.1007/s002130050892
Foley, 2004, Childhood adversity, monoamine oxidase A genotype, and risk for conduct disorder, Arch Gen Psychiatry, 61, 738, 10.1001/archpsyc.61.7.738
Glatt, 2003, Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia, Am J Psychiatry, 160, 469, 10.1176/appi.ajp.160.3.469
Gottesman, 2003, The endophenotype concept in psychiatry, Am J Psychiatry, 160, 636, 10.1176/appi.ajp.160.4.636
Hardin, 2001
Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen H-U, et al (2004): Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Br Med J. Available: BMJ, doi:10.1136/bmj.38267.664086.63 (published 1 December 2004).
Johns, 2001, The continuity of psychotic experiences in the general population, Clinical Psychol Rev, 21, 1125, 10.1016/S0272-7358(01)00103-9
Kapur, 2003, Psychosis as a state of aberrant salience, Am J Psychiatry, 160, 13, 10.1176/appi.ajp.160.1.13
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (in press): The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry.
Kennedy, 2003, The genetics of adult-onset neuropsychiatric disease, Science, 302, 822, 10.1126/science.1092132
Kim-Cohen, 2003, Prior juvenile diagnoses in adults with mental disorder, Arch Gen Psychiatry, 60, 709, 10.1001/archpsyc.60.7.709
Lachman, 1996, Human catechol-O-methyltransferase pharmacogenetics, Pharmacogenetics, 6, 243, 10.1097/00008571-199606000-00007
Lewis, 2003, Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II, Am J Hum Genet, 73, 34, 10.1086/376549
Licinio, 2003, Moving away from one-polymorphism genetic association studies, Mol Psychiatry, 8, 247, 10.1038/sj.mp.4001330
Lotta, 1995, Kinetics of human soluble and membrane-bound catechol-O-methyltransferase, Biochemistry, 34, 4202, 10.1021/bi00013a008
Lundqvist, 2001, Frontal lobe dysfunction in long-term cannabis users, Neurotoxicol Teratol, 23, 437, 10.1016/S0892-0362(01)00165-9
Lynskey, 2003, Escalation of drug use in early-onset cannabis users vs co-twin controls, JAMA, 289, 427, 10.1001/jama.289.4.427
Männisto, 1999, Catechol-O-methyltransferase (COMT), Pharmacol Rev, 51, 593
McClay, 2002, High-throughput single-nucleotide polymorphism genotyping by fluorescent competitive allele-specific polymerase chain reaction (SNiPTag), Anal Biochem, 301, 200, 10.1006/abio.2001.5509
Moffitt TE, Caspi A, RutterM(in press): Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry.
Moffitt, 2001
Moore, 1999, The regulation of forebrain dopamine transmission, Biol Psychiatry, 46, 40, 10.1016/S0006-3223(99)00078-5
Murphy, 1999, High rates of schizophrenia in adults with velo-cardio-facial syndrome, Arch Gen Psychiatry, 56, 940, 10.1001/archpsyc.56.10.940
Myin-Germeys, 2003, Continuity of psychotic symptoms in the community, Curr Opin Psychiatry, 16, 443, 10.1097/01.yco.0000079208.36371.cd
Ordovas, 2002, Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism, Circulation, 106, 2315, 10.1161/01.CIR.0000036597.52291.C9
Palmatier, 1999, Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles, Biol Psychiatry, 46, 557, 10.1016/S0006-3223(99)00098-0
Pistis, 2004, Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons, Biol Psychiatry, 56, 86, 10.1016/j.biopsych.2004.05.006
Pope, 2003, Early-onset cannabis use and cognitive deficits, Drug Alcohol Depend, 69, 303, 10.1016/S0376-8716(02)00334-4
Poulton, 2000, Children’s self-reported psychotic symptoms predict adult schizophreniform disorders, Arch Gen Psychiatry, 57, 1053, 10.1001/archpsyc.57.11.1053
Rhee, 2003, Genetic and environmental influences on substance initiation, use, and problem use in adolescents, Arch Gen Psychiatry, 60, 1256, 10.1001/archpsyc.60.12.1256
Robins, 1995
Schneider, 2003, Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats, Neuropsychopharmacology, 28, 1760, 10.1038/sj.npp.1300225
Shifman, 2002, A highly-significant association between a COMT haplotype and schizophrenia, Am J Hum Genet, 71, 1296, 10.1086/344514
Solowij, 2002, Cognitive functioning of long-term heavy cannabis users seeking treatment, JAMA, 287, 1123, 10.1001/jama.287.9.1123
2003
Stefanis, 2004, Early adolescent cannabis exposure and positive and negative dimensions of psychosis, Addiction, 99, 1333, 10.1111/j.1360-0443.2004.00806.x
Tanda, 1997, Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism, Science, 276, 2048, 10.1126/science.276.5321.2048
Veen, 2004, Cannabis use and age at onset of schizophrenia, Am J Psychiatry, 161, 501, 10.1176/appi.ajp.161.3.501
Verdoux, 2003, Effects of cannabis and psychosis vulnerability in daily life, Psychol Med, 33, 23, 10.1017/S0033291702006384
Verrico, 2003, Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated intermittent cannabinoid administration to rats, Synapse, 49, 61, 10.1002/syn.10215
Voruganti, 2001, Cannabis induced dopamine release, Psychiatr Res, 107, 173, 10.1016/S0925-4927(01)00104-4
Wechsler, 1974